Health ❯Healthcare ❯Obesity

Chronic Diseases

Economic Impact Access to Treatment

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities